Imaging the unimaginable: leveraging signal generation of CRISPR-Cas for sensitive genome imaging

Trends Biotechnol. 2023 Jun;41(6):769-784. doi: 10.1016/j.tibtech.2022.10.003. Epub 2022 Nov 8.

Abstract

Fluorescence in situ hybridization (FISH) is the gold standard for visualizing genomic DNA in fixed cells and tissues, but it is incompatible with live-cell imaging, and its combination with RNA imaging is challenging. Consequently, due to its capacity to bind double-stranded DNA (dsDNA) and design flexibility, the clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein 9 (CRISPR-Cas9) technology has sparked enormous interest over the past decade. In this review, we describe various nucleic acid (NA)- and protein-based (amplified) signal generation methods that achieve imaging of repetitive and single-copy sequences, and even single-nucleotide variants (SNVs), next to highly multiplexed as well as dynamic imaging in live cells. With future progress in the field, the CRISPR-(d)Cas9-based technology promises to break through as a next-generation cell-imaging technique.

Keywords: CRISPR-Cas9; fixed-cell imaging; genome imaging; live-cell imaging; signal amplification.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • CRISPR-Cas Systems*
  • DNA / genetics
  • DNA / metabolism
  • Diagnostic Imaging
  • Genome*
  • In Situ Hybridization, Fluorescence

Substances

  • DNA